Vitamin Biomarkers Global Market Report 2026

Vitamin biomarkers are indicators in the body that can be measured to reflect the levels or status of specific vitamins. They help evaluate an individual's nutritional condition and assist in identifying deficiencies or excesses of certain vitamins. These biomarkers are typically assessed through blood, urine, or tissue samples and offer insights into the body's ability to absorb, metabolize, and utilize vitamins effectively.

The primary types of vitamin biomarkers include serum retinol (vitamin A), ascorbic acid (vitamin C), serum 25(OH)D (vitamin D), serum alpha-tocopherol (vitamin E), serum prothrombin (vitamin K), serum thiamine diphosphate (vitamin B1), serum glycolate (vitamin B2), serum niacin (vitamin B3), serum plasma PLP (vitamin B6), among others. Serum retinol, also referred to as vitamin A, is a biomarker that quantifies the level of retinol in the bloodstream, playing a crucial role in vision, immune system function, and skin health, while also aiding in the detection of vitamin A deficiencies or excesses. The offerings comprise analyzers, test kits, reagents, and consumables, employing testing methods such as enzyme-linked immunosorbent assays (ELISA), liquid chromatography with tandem mass spectrometry (LC-MS/MS), high-performance liquid chromatography (HPLC), and chemiluminescent immunoassays (CLIA) for end users including hospitals, diagnostic laboratories, ambulatory diagnostic centers, and homecare services.

Tariffs have raised the cost of imported analyzers, reagents, and diagnostic consumables used in advanced laboratory testing workflows. These effects are most evident in high complexity methods such as LC MS MS, where precision instruments and specialized reagents are critical. Regions such as North America and Europe have experienced higher input costs due to reliance on global diagnostic supply chains. Rising tariff related expenses have influenced capital investment decisions and testing service pricing. However, tariffs have encouraged regional diagnostic manufacturing, local reagent production, and stronger in region laboratory ecosystems over the long term.

The vitamin biomarkers market research report is one of a series of new reports from The Business Research Company that provides vitamin biomarkers market statistics, including vitamin biomarkers industry global market size, regional shares, competitors with a vitamin biomarkers market share, detailed vitamin biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the vitamin biomarkers industry. This vitamin biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vitamin biomarkers market size has grown rapidly in recent years. It will grow from $4.02 billion in 2025 to $4.52 billion in 2026 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to increased nutritional deficiency awareness, growth in diagnostic laboratories, expansion of elisa testing, improved healthcare screening, rise in chronic diseases.

The vitamin biomarkers market size is expected to see rapid growth in the next few years. It will grow to $7.18 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to growth in preventive healthcare, expansion of personalized nutrition, increasing diagnostic automation, rise in home-based testing, growing elderly population. Major trends in the forecast period include rising demand for nutritional deficiency testing, increasing use of advanced diagnostic assays, growing focus on preventive healthcare diagnostics, expansion of laboratory-based vitamin testing, increased adoption of high-precision testing methods.

The rising prevalence of nutrient deficiencies is anticipated to drive the expansion of the vitamin biomarkers industry in the coming years. Nutrient deficiencies occur when the diet lacks essential nutrients, resulting in negative health consequences. The increase in nutrient deficiencies is primarily attributed to higher consumption of unbalanced diets and highly processed foods, which often do not provide the necessary vitamins and minerals for maintaining good health. Vitamin biomarkers help identify nutrient deficiencies by measuring specific vitamins in the bloodstream, enabling the assessment of nutritional status and guiding appropriate interventions. For example, in January 2025, The Guardian, a UK-based news and media outlet, reported 191,927 hospital admissions in 2023-24 due to iron deficiency, marking an 11 percent rise from 2022-23, and 2,630 admissions due to B vitamin deficiencies other than folate, up 15 percent from the previous year. Consequently, the growing prevalence of nutrient deficiencies is expected to fuel the demand for vitamin biomarkers.

Major players in the vitamin biomarker sector are increasingly focusing on at-home, lab-quality testing kits that allow users to track essential nutrients like vitamin D with ease, accuracy, and affordability. These advancements promote preventive healthcare by widening access to nutrient-level information, enabling both individuals and healthcare providers to implement personalized interventions based on real-time biomarker data. For example, in February 2023, Hurdle, a US-based diagnostics platform operated by Chronomics Inc., introduced a vitamin D test that uses a simple finger-prick sample to deliver quantitative, lab-quality results from the comfort of home. The test provides results, along with explanations of vitamin D's functions in the body and possible reasons for abnormal levels, within three days through a secure personal dashboard. This introduction reflects broader industry trends, including increasing global awareness of vitamin D deficiency, rising demand for remote testing, and the integration of wellness diagnostics into telehealth and preventive care.

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based medical equipment manufacturer, acquired a 75% stake in DiaSys Diagnostic Systems GmbH for an undisclosed amount. This acquisition is set to strengthen Mindray's presence in diagnostic solutions and broaden its technological capabilities. DiaSys Diagnostic Systems GmbH is a Germany-based company engaged in the research and development of various biomarkers, including those associated with vitamins.

Major companies operating in the vitamin biomarkers market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Roche Diagnostics International Ltd., Agilent Technologies Inc, PerkinElmer Inc, bioMerieux SA, Beckman Coulter Inc, Shimadzu Corporation, QuidelOrtho Corporation, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc, Tecan Group Ltd, Randox Laboratories Ltd, Ortho Clinical Diagnostics Inc, Molecular Devices LLC, Cambridge Isotope Laboratories Inc, Luminex Corporation, DiaSorin SpA, Analytik Jena AG, SeraCare Life Sciences Inc, Biopanda Reagents Ltd, SiPhox Inc

North America was the largest region in the vitamin biomarkers market in 2025. The regions covered in the vitamin biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vitamin biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vitamin biomarkers market consists of revenues earned by entities by providing services such as vitamin level testing, diagnostic assessments, nutritional monitoring, and personalized health management to detect deficiencies or excesses of specific vitamins. The market value includes the value of related goods sold by the service provider or included within the service offering. The vitamin biomarkers market also includes sales of diagnostic assays, test kits, laboratory reagents, analytical instruments, and point-of-care devices used to measure and analyze vitamin levels in biological samples. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vitamin Biomarkers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses vitamin biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vitamin biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vitamin biomarkers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Biomarker Type: Serum Retinol (Vitamin A); Ascorbic Acid (Vitamin C); Serum 25(OH)D (Vitamin D); Serum Alpha-tocopherol (Vitamin E); Serum Prothrombin (Vitamin K); Serum Thiamine Diphosphate (Vitamin B1); Serum Glycolate (Vitamin B2); Serum Niacin (Vitamin B3); Serum Plasma PLP (Vitamin B6); Other Biomarker Types
• 2) By Product: Analyzers; Test Kits; Reagents And Consumables
• 3) By Testing Method: Enzyme Linked Immunosorbent Assay (ELISA); Liquid Chromatography With Tandem Mass Spectrometry (LC MS MS); High Performance Liquid Chromatography (HPLC); Chemiluminescent Immunoassay (CLIA)
• 4) By End User: Hospitals; Diagnostic Laboratories; Ambulatory Diagnostic Centers; Homecare Settings
• Subsegments:
• 1) By Serum Retinol (Vitamin A): Retinol Measurement Kits; Retinol Assay Reagents
• 2) By Ascorbic Acid (Vitamin C): Vitamin C Detection Kits; Ascorbic Acid Assay Reagents
• 3) By Serum 25(OH)D (Vitamin D): Vitamin D Testing Kits; 25-Hydroxyvitamin D Assay Reagents
• 4) By Serum Alpha-tocopherol (Vitamin E): Alpha-tocopherol Measurement Kits; Vitamin E Assay Reagents
• 5) By Serum Prothrombin (Vitamin K): Prothrombin Time Testing Kits; Vitamin K Assay Reagents
• 6) By Serum Thiamine Diphosphate (Vitamin B1): Thiamine Measurement Kits; Vitamin B1 Assay Reagents
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Siemens Healthineers AG; Roche Diagnostics International Ltd.; Agilent Technologies Inc; PerkinElmer Inc; bioMerieux SA; Beckman Coulter Inc; Shimadzu Corporation; QuidelOrtho Corporation; Sysmex Corporation; Waters Corporation; Bio-Rad Laboratories Inc; Tecan Group Ltd; Randox Laboratories Ltd; Ortho Clinical Diagnostics Inc; Molecular Devices LLC; Cambridge Isotope Laboratories Inc; Luminex Corporation; DiaSorin SpA; Analytik Jena AG; SeraCare Life Sciences Inc; Biopanda Reagents Ltd; SiPhox Inc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.